Vanderbilt University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1873-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vanderbilt.edu
Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
Not Applicable
Completed
- Conditions
- SchizophreniaSchizoaffective DisorderDepressive Disorder, MajorBipolar Disorder
- Interventions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-08-26
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 300
- Registration Number
- NCT00179062
- Locations
- 🇺🇸
Psychiatric Hospital at Vanderbilt, Nashville, Tennessee, United States
Complementary Intradialytic Nutritional Supplementation in Dialysis Patients
Phase 2
Terminated
- Conditions
- End Stage Renal Disease
- Interventions
- Drug: Nepro nutritional supplementDrug: placebo
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-08-06
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 27
- Registration Number
- NCT00179205
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis
Phase 2
Completed
- Conditions
- End Stage Renal Disease
- Interventions
- Drug: nutritional supplementationBehavioral: exercise
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2009-07-09
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 11
- Registration Number
- NCT00179179
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
Phase 2
Completed
- Conditions
- Mycosis FungoidesCutaneous T-cell LymphomaSezary Syndrome
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 4
- Registration Number
- NCT00178841
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients
Completed
- Conditions
- Parkinson's Disease
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2006-08-15
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 42
- Registration Number
- NCT00179101
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Vanderbilt University Spasticity Management Program Evaluation Plan
Phase 4
Completed
- Conditions
- Spasticity
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2007-08-20
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 20
- Registration Number
- NCT00179114
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Sertraline vs. Venlafaxine XR
Phase 3
Completed
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2015-06-02
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 20
- Registration Number
- NCT00179283
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy.
Phase 2
Completed
- Conditions
- Chronic Idiopathic Axonal Polyneuropathy
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-01-11
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 30
- Registration Number
- NCT00156689
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)
Phase 2
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2013-03-22
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 455
- Registration Number
- NCT00141778
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
The MIND Study: Modifying the INcidence of Delirium
Phase 2
Completed
- Conditions
- DeliriumCognition Disorders
- Interventions
- First Posted Date
- 2004-11-17
- Last Posted Date
- 2016-01-29
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 102
- Registration Number
- NCT00096863
- Locations
- 🇺🇸
University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States
🇺🇸Moses Cone, Greensboro, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath